Deutsch English Français

Contact

EP2773638

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2773638

EP2773638 - HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 12.08.2016 Database last updated on 23.04.2024
Most recent event Tooltip	12.10.2018	Lapse of the patent in a contracting state New state(s): AL	published on 14.11.2018 [2018/46]
Applicant(s)	For all designated states F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
	[N/P]
Former [2014/37]	For all designated states F.Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH
Inventor(s)	01 / CRAWFORD, James John c/o Genentech Inc. 1 DNA Way South San Francisco, California 94080 / US
	02 / ORTWINE, Daniel Fred c/o Genentech Inc. 1 DNA Way South San Francisco, California 94080 / US
	03 / WEI, BinQing c/o Genentech Inc. 1 DNA Way South San Francisco, California 94080 / US
	04 / YOUNG, Wendy B. c/o Genentech Inc. 1 DNA Way South San Francisco, California 94080 / US
	[2014/37]
Representative(s)	Sauer, Frank F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124 4070 Basel / CH
	[2014/37]
Application number, filing date	12783837.3	02.11.2012
	[2015/41]
	WO2012US63194
Priority number, date	US201161555393P	03.11.2011 Original published format: US 201161555393 P
	[2014/37]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013067274
	Date:	10.05.2013
	Language:	EN
	[2013/19]
	Type:	A1 Application with search report
	No.:	EP2773638
	Date:	10.09.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 10.05.2013 takes the place of the publication of the European patent application.
	[2014/37]
	Type:	B1 Patent specification
	No.:	EP2773638
	Date:	07.10.2015
	Language:	EN
	[2015/41]
Search report(s)	International search report - published on:	EP	10.05.2013
Classification	IPC:	C07D471/04, C07D471/14, C07D487/04, C07D495/04, C07D519/00, A61K31/4985, C07D487/14, A61K31/381, A61K31/4353, A61P35/00, A61P37/00	[2014/37]
	CPC:	C07D487/04 (EP,CN,US); C07D487/14 (EP,CN,US); A61K31/495 (EP,US); A61K31/496 (EP,CN,US); A61K31/497 (CN); A61K31/4985 (EP,CN,US); (+) A61K31/4995 (EP,CN,US); A61K31/501 (EP,CN,US); A61K31/5025 (EP,CN,US); A61K31/506 (EP,CN,US); A61K31/53 (EP,CN,US); A61K31/5377 (EP,CN,US); A61K31/5383 (EP,CN,US); A61K45/06 (US); A61K9/20 (US); A61P35/00 (EP,US); A61P37/00 (EP,US); C07D401/14 (EP); C07D405/14 (EP); C07D471/04 (EP,CN,US); C07D471/14 (EP,CN,US); C07D487/08 (EP,CN,US); C07D495/04 (EP,CN,US); C07D495/14 (EP,CN,US); C07D498/04 (EP,CN,US); C07D513/04 (EP,CN,US); C07D519/00 (EP,CN,US); C07F7/1804 (EP) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/37]
Extension states	BA	Not yet paid
	ME	Not yet paid
Title	German:	HETEROARYLPYRIDON- UND AZA-PYRIDONVERBINDUNGEN ALS BTK-AKTIVITÄTS-HEMMER	[2014/37]
	English:	HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY	[2014/37]
	French:	COMPOSÉS HÉTÉROARYL PYRIDONES ET AZA-PYRIDONES EN TANT QU'INHIBITEURS DE L'ACTIVITÉ BTK	[2014/37]
Entry into regional phase	03.06.2014	National basic fee paid
	03.06.2014	Designation fee(s) paid
	03.06.2014	Examination fee paid
Examination procedure	03.06.2014	Examination requested [2014/37]
	16.01.2015	Amendment by applicant (claims and/or description)
	28.04.2015	Communication of intention to grant the patent
	25.08.2015	Fee for grant paid
	25.08.2015	Fee for publishing/printing paid
	25.08.2015	Receipt of the translation of the claim(s)
Divisional application(s)	EP15188086.1 / EP3002284
	EP19152979.1 / EP3521288
	EP21171114.8
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.04.2015
Opposition(s)	08.07.2016	No opposition filed within time limit [2016/37]
Fees paid	Renewal fee
	07.11.2014	Renewal fee patent year 03
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	07.10.2015
	MK	07.10.2015
	SM	07.10.2015
	IS	07.02.2016
	[2018/46]
Former [2018/31]	MK	07.10.2015
	SM	07.10.2015
	IS	07.02.2016
Former [2016/38]	SM	07.10.2015
	IS	07.02.2016
Former [2016/27]	IS	07.02.2016
Former [2016/25]	LV	07.10.2015
	IS	07.02.2016
Former [2016/22]	IS	07.02.2016
Cited in	International search	[AD]WO2009039397 (CGI PHARMACEUTICALS INC [US], et al) [AD] 1-29 * example - ** claim - *;
		[A]WO2010100070 (HOFFMANN LA ROCHE [CH], et al) [A] 1-29 * example - * * claim - *;
		[A]WO2010122038 (HOFFMANN LA ROCHE [CH], et al) [A] 1-29 * example - * * claim - *
	by applicant	US3773919
		WO9615111
		US5583024
		US5674713
		US5700670
		US6602677
		US2004254066
		WO2006053121
		WO2007044515
		US2008125417
		US2008139557
		US7393848
		US7405295
		US2009318448
		WO2010056875
		US7838523
		US7884108
		US2011118233
		US7947835
		- DI PAOLO ET AL., NATURE CHEM. BIOL., (2011), vol. 7, no. 1, pages 41 - 50
		- LIU ET AL., JOUR. OF PHARM. AND EXPER. THER., (2011), vol. 338, no. 1, pages 154 - 163
		- LIU, DRUG METAB. AND DISPOSITION, (2011), vol. 39, no. 10, pages 1840 - 1849
		- The Chemistry of Heterocyclic Compounds, A series of Monographs, JOHN WILEY & SONS, (1950), vol. 13, 14,
		- J. AM. CHCM. SOC., (1960), vol. 82, page 5566
		- ANGEW CHEM. INTL. ED. ENGL., (1994), vol. 33, pages 183 - 186
		- BIOCHEM. PHARMACOL., (1973), vol. 22, page 3099
		- HONIGBERG ET AL., PROC. NATL. ACAD. SCI., (2010), vol. 107, no. 29, pages 13075 - 13080
		- CROUCH ET AL., J. IMMUNOL. METH., (1993), vol. 160, pages 81 - 88
		- CREE, ANTICANCER DRUGS, (1995), vol. 6, pages 398 - 404
		- Remington's Phannaceutical Sciences, MACK PUBLISHING CO.
		- Comprehensive Heterocyclic Chemistry II, ELSEVIER, (1997), vol. 3
		- LIEBIGS ANNALEN DER CHEMIE, pages 1910 - 16
		- HELVETICA CHIMICA ACTA, (1958), vol. 41, pages 1052 - 60
		- ARZNEIMITTEL-FORSCHUNG, (1990), vol. 40, no. 12, pages 1328 - 31
		- LOUIS F. FIESER; MARY FIESER, Reagentsfor Organic Synthesis, WILEY, (1967), vol. 1-23
		- SUZUKI, PURE APPL. CHEM., (1991), vol. 63, pages 419 - 422
		- MIYAURA; SUZUKI, CHEM. REVIEWS, (1979), vol. 95, no. 7, pages 2457 - 2483
		- SUZUKI, J. ORGANOMETAL. CHEM., (1999), vol. 576, pages 147 - 168
		- WOLF; BUCHWALD, ORG. SYNTH COLL., (2004), vol. 10, page 423
		- PAUL ET AL., JOUR. AMER. CHEM. SOC., (1994), vol. 116, pages 5969 - 5970
		- LOCHMULLER, C. H., J. CHROMATOGR., (1975), vol. 113, no. 3, pages 283 - 302
		- E.; WILCN, S., Stereochemistry of Organic Compounds, JOHN WILEY & SONS, INC., (1994), page 322
		- JACOB III., J. ORG. CHEM., (1982), vol. 47, page 4165
		- OKAMOTO, J. CHROMATOGR., (1990), vol. 513, pages 375 - 378
		- ORGANIC PREPARATIONS AND PROCEDURES INT., vol. 29, no. 4, pages 471 - 498
		WO2011US50034
		WO2011US50013

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p